RT @edenhelmi: Too little antibiotic isn't good But how about too much? Can this increase mortality too like this paper: Increased death p…
RT @edenhelmi: Too little antibiotic isn't good But how about too much? Can this increase mortality too like this paper: Increased death p…
RT @edenhelmi: Too little antibiotic isn't good But how about too much? Can this increase mortality too like this paper: Increased death p…
RT @SyamhaninA: Something worth to consider when starting a patient on continuous infusion.. https://t.co/VUstzpyLOM
RT @edenhelmi: Too little antibiotic isn't good But how about too much? Can this increase mortality too like this paper: Increased death p…
RT @edenhelmi: Too little antibiotic isn't good But how about too much? Can this increase mortality too like this paper: Increased death p…
RT @SyamhaninA: Something worth to consider when starting a patient on continuous infusion.. https://t.co/VUstzpyLOM
Something worth to consider when starting a patient on continuous infusion..
Too little antibiotic isn't good But how about too much? Can this increase mortality too like this paper: Increased death perhaps related to - neutotoxicity SE or - Potentiation of SAKI (sepsis induced AKI) as PIP itself may cause nephrotoxicity https
Thanks @SIDPharm and @ErinMcCreary for this podcast (https://t.co/DPF8XVdchT) on piperacillin presented at EECMID Via this, I know about an interesting TDM-based study (largest to-date) in a German ICU. Too much of piperacillin might also be deadly. ht
Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience. https://t.co/1Gb7VbvqxQ